| 1 |
Lin B, Dong X, Wang Q, Li W, Zhu M, Li M. AFP-Inhibiting Fragments for Drug Delivery: The Promise and Challenges of Targeting Therapeutics to Cancers. Front Cell Dev Biol 2021;9:635476. [PMID: 33898423 DOI: 10.3389/fcell.2021.635476] [Reference Citation Analysis]
|
| 2 |
Pak VN. The use of alpha-fetoprotein for the treatment of autoimmune diseases and cancer. Ther Deliv 2018;9:37-46. [PMID: 29216804 DOI: 10.4155/tde-2017-0073] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 3 |
Pak VN. Selective targeting of myeloid-derived suppressor cells in cancer patients through AFP-binding receptors. Future Sci OA 2019;5:FSO321. [PMID: 30652015 DOI: 10.4155/fsoa-2018-0029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Pak VN. α-fetoprotein-binding toxins and teratogens against cancer. Ther Deliv 2019;10:1-3. [PMID: 30730821 DOI: 10.4155/tde-2018-0068] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 5 |
Lin B, Wang Q, Liu K, Dong X, Zhu M, Li M. Alpha-Fetoprotein Binding Mucin and Scavenger Receptors: An Available Bio-Target for Treating Cancer. Front Oncol 2021;11:625936. [PMID: 33718192 DOI: 10.3389/fonc.2021.625936] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Mizejewski GJ. The alpha-fetoprotein third domain receptor binding fragment: in search of scavenger and associated receptor targets. Journal of Drug Targeting 2015;23:538-51. [DOI: 10.3109/1061186x.2015.1015538] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 7 |
Gulevskyy OK; Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkiv. URRENT CONCEPT OF THE STRUCTURAL AND FUNCTIONAL PROPERTIES OF ALFA-FETOPROTEIN AND THE POSSIBILITIES OF ITS CLINICAL APPLICATION. Biotechnol acta 2021;14:25-37. [DOI: 10.15407/biotech14.01.025] [Reference Citation Analysis]
|
| 8 |
Belyaev NN, Abdolla N, Perfilyeva YV, Ostapchuk YO, Krasnoshtanov VK, Kali A, Tleulieva R. Daunorubicin conjugated with alpha-fetoprotein selectively eliminates myeloid-derived suppressor cells (MDSCs) and inhibits experimental tumor growth. Cancer Immunol Immunother 2018;67:101-11. [DOI: 10.1007/s00262-017-2067-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
|
